Photographers Kevin Black and Dave Clements have released the third of their three-volume "Raising A Hand" series that raises money for Rett syndrome research.
After failing to receive the RMAT designation from the FDA for its early-stage Batten disease gene therapy, Neurogene tells ...
Two months after giving birth to their daughter, Jayla, Shelly Balboa and her partner, Joseph, noticed the left side of their ...
Keith Tapper CFA, an analyst from BMO Capital, maintained the Buy rating on Neurogene (NGNE – Research Report). The associated price target ...
Dee Cowburn, advocating for her disabled daughter, is concerned about a Bill on assisted dying. Kim Leadbeater, the MP behind ...
The WAG, 38, spoke to her campmates about Rosie, who tragically passed away in 2013 aged 14 after a lifelong battle with Rett ...
Neurogene has dropped plans to keep studying the high dose of its Rett syndrome gene therapy because of an adverse event that ...
In an update posted today, Neurogene said that the "emerging treatment-related serious adverse event (SAE)" was a case of systemic hyperinflammatory syndrome, a rare and life-threatening immune ...
Coleen Rooney has bravely opened up about the loss of her younger sister Rosie McLoughlin, leading many fans to want to know ...
Talks with the FDA haven’t gone according to plan. Seeking a streamlined pathway, Neurogene submitted a Regenerative Medicine ...
Neurogene (NGNE) announced an update on its ongoing Phase 1/2 open-label clinical trial evaluating NGN-401 gene therapy for the treatment of ...
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced third quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback